DR. MARK A MILLER
Osteopathic Medicine at Leland St, Bethesda, MD
License number
Maryland 035477
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address
4411 Leland St, Bethesda, MD 20815
Phone
(301) 496-0815
Organization information
See more information about MARK A MILLER at bizstanding.comMark Miller
Bethesda, MD - Washington, DC
Industry:
Medical Doctor's Office
Addresses:
4411 Leland St, Bethesda, MD 20815
1735 S St NW, Washington, DC 20009
2420 14 St NW, Washington, DC 20009
1735 S St NW, Washington, DC 20009
2420 14 St NW, Washington, DC 20009
Principal:
Mark A. Miller (Principal)
Professional information
Dr. Mark A Miller, Chevy Chase MD - MD (Doctor of Medicine)
Specialties:
Internal Medicine, Neuropsychiatry (Psychiatry)
Address:
4411 Leland St, Chevy Chase 20815
(301) 496-0815 (Phone)
(301) 496-0815 (Phone)
Certifications:
Internal Medicine, 2004, Psychiatry, 1987
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
State University of New York / Health Science Center At Stony Brook
Graduated: 1981
Duke University Hospital
State University of New York / Health Science Center At Stony Brook
Graduated: 1981
Duke University Hospital
Mark William Miller, Bethesda MD
Specialties:
Sleep Medicine Specialist
Address:
Attn Credential, Bethesda, MD 20889
18101 Prince Philip Dr, Olney, MD 20832
1395 Piccard Dr, Rockville, MD 20850
18101 Prince Philip Dr, Olney, MD 20832
1395 Piccard Dr, Rockville, MD 20850
Education:
Doctor of Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Sleep Medicine (Internal Medicine)
Vaccines Against Influenza Virus
US Patent:
2010015, Jun 17, 2010
Filed:
Aug 14, 2009
Appl. No.:
12/541804
Inventors:
Mark A. Miller - Chevy Chase MD, US
Rachel Schneerson - Bethesda MD, US
John B. Robbins - New York NY, US
Jerry Keith - Olney MD, US
Rachel Schneerson - Bethesda MD, US
John B. Robbins - New York NY, US
Jerry Keith - Olney MD, US
International Classification:
A61K 39/385, A61P 31/16, C07K 17/06
US Classification:
4241941, 530404
Abstract:
Disclosed are immunogenic conjugates having the general formula:were M2e is the influenza M2 ectodomain (M2e) peptide; Cys is a cysteine amino acid residue present in the M2e peptide; S the sulfur present in the cysteine amino acid residue; CH2-CO—NH—CH2-CH2-CO the linking group; NH the amine group present in a lysine residue of the carrier; Lys is a lysine amino acid residue and Pr the carrier protein. Also disclosed are isolated immunogens that include an immunogenic fragment of an influenza HA protein including the polybasic cleavage site, wherein the immunogenic fragment of the influenza HA protein has been modified to remove an N-terminal leader amino acid sequence and a C-terminal transmembrane domain. Also disclosed are methods producing an influenza vaccine specific for an identified influenza strain.